Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide
1. Department of Information Engineering, University of Padova, Padova, Italy;2. R&D Data & Data Science, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany